Literature DB >> 19734968

Histology-based treatment of basal cell carcinoma.

Klara Mosterd1, Aimee H M M Arits, Monique R T Thissen, Nicole W J Kelleners-Smeets.   

Abstract

Basal cell carcinoma is the most common type of skin cancer and its incidence is still rising. In recent years, new treatment modalities have been developed and existing modalities refined. The aim of this article is to give a histology-based overview of the available evidence-based research. The literature was searched for randomized controlled trials from which the efficacy of investigated treatments was obtained. Where possible, treatment modalities were evaluated specifically. Selection criteria were histological subtype, primary or recurrent basal cell carcinoma and tumour localization. Although surgery remains the preferred treatment for most basal cell carcinomas, patient and tumour characteristics should be taken into account when choosing the most suitable treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734968     DOI: 10.2340/00015555-0710

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

1.  Basal cell carcinoma.

Authors:  Christiane Matuschek; Norman Philipp Hoff; Matthias Peiper; Wilfried Budach; Peter Arne Gerber; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

2.  Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.

Authors:  Ozben Yalcin; Engin Sezer; Fevziye Kabukcuoglu; Ayse Irem Kilic; Ahu Gulcin Sari; Asli Aksu Cerman; Ilknur Kivanc Altunay
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.

Authors:  Tjinta Brinkhuizen; Karin van den Hurk; Véronique J L Winnepenninckx; Joep P de Hoon; Ariënne M van Marion; Jürgen Veeck; Manon van Engeland; Maurice A M van Steensel
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

4.  Characteristics of Mixed Type Basal Cell Carcinoma in Comparison to Other BCC Subtypes.

Authors:  A Ghanadan; A Abbasi; M Rabet; P Abdollahi; Ma Abbasi
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

5.  Comparison of basal cell carcinoma subtypes observed in preoperative biopsy and Mohs micrographic surgery.

Authors:  Felipe Bochnia Cerci; Elisa Mayumi Kubo; Betina Werner
Journal:  An Bras Dermatol       Date:  2020-06-27       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.